China Resources Sanjiu participated in the project "Construction and Application of an Innovative Technology System for Analyzing the Mechanism of Action of Traditional Chinese Medicine Centered on Functional Substances," which won the second prize of the 2025 National Science and Technology Progress Award. The project was led by Guangzhou University of Chinese Medicine and involved over twenty years of research, establishing an integrated full-chain technology platform covering functional substance discovery, biosynthesis, mechanism analysis, and clinical translation. As a participating unit, China Resources Sanjiu leveraged this technology system to complete pharmacodynamic substance basis research, quality marker discovery, process optimization, and standard upgrades for 999 Ganmaoling, Sanjiu Weitai, and several ancient classic formula compound preparations. This resulted in improved product quality stability and clinical efficacy reliability. The company stated that technological innovation is the core engine of its development, and it will continue to deepen collaborative innovation, accelerate the industrial translation of cutting-edge achievements in functional substance research of traditional Chinese medicine, and promote the high-quality development of the traditional Chinese medicine industry.
China Resources Sanjiu Medical & Pharmaceutical Co LtdCompany participated in award-winning project for TCM mechanism analysis technology, improving product quality and clinical efficacy.